MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$3,240K
(0.25%↑ Y/Y)
Accounts receivable
$1,000K
(79.86%↑ Y/Y)
Prepaid expenses
$384K
(-8.79%↓ Y/Y)
Other current assets
$11K
(-31.25%↓ Y/Y)
Other investment
$5,350K
(0.00%↑ Y/Y)
Total current assets
$4,635K
(9.70%↑ Y/Y)
Total assets
$9,985K
(4.28%↑ Y/Y)
Total liabilities and
stockholders' equity
$9,985K
(4.28%↑ Y/Y)
Total stockholders'
equity
$9,085K
(2.66%↑ Y/Y)
Total current
liabilities
$900K
(24.14%↑ Y/Y)
Accumulated deficit
-$271,020K
(-1.32%↓ Y/Y)
Paid-in capital
$280,105K
(1.36%↑ Y/Y)
Accounts payable
$508K
(30.26%↑ Y/Y)
Accrued research and
development costs
$198K
(280.77%↑ Y/Y)
Accrued expenses and
other current...
$194K
(-31.45%↓ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
Cyclerion Therapeutics, Inc. (CYCN)
Cyclerion Therapeutics, Inc. (CYCN)